H. B. Fuller (NYSE:FUL) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of H. B. Fuller (NYSE:FUL) from a buy rating to a hold rating in a research report report published on Monday morning.

FUL has been the topic of several other reports. Citigroup upgraded H. B. Fuller from a “neutral” rating to a “buy” rating and lifted their target price for the company from $62.00 to $70.00 in a research note on Wednesday, October 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of H. B. Fuller in a research report on Monday, November 17th. Seaport Res Ptn raised shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. Finally, UBS Group initiated coverage on shares of H. B. Fuller in a research note on Friday, November 21st. They issued a “neutral” rating and a $60.00 target price for the company. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $66.20.

H. B. Fuller Stock Performance

Shares of H. B. Fuller stock opened at $58.71 on Monday. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of 31.74, a PEG ratio of 1.05 and a beta of 1.13. The firm’s fifty day simple moving average is $58.49 and its 200-day simple moving average is $58.60. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.93 and a quick ratio of 1.18. H. B. Fuller has a 12 month low of $47.56 and a 12 month high of $77.77.

H. B. Fuller (NYSE:FUL) last announced its earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 EPS for the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%. The business had revenue of $725.90 million during the quarter. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. As a group, equities analysts forecast that H. B. Fuller will post 4.07 earnings per share for the current year.

H. B. Fuller Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 30th. Stockholders of record on Thursday, October 16th were paid a dividend of $0.235 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend was Thursday, October 16th. H. B. Fuller’s dividend payout ratio (DPR) is 50.81%.

Insider Activity at H. B. Fuller

In other H. B. Fuller news, CFO John J. Corkrean sold 14,222 shares of the firm’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $60.31, for a total transaction of $857,728.82. Following the completion of the transaction, the chief financial officer owned 54,646 shares of the company’s stock, valued at approximately $3,295,700.26. This trade represents a 20.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Nathan D. Weaver sold 7,075 shares of the business’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $58.38, for a total value of $413,038.50. Following the completion of the transaction, the vice president directly owned 9,441 shares of the company’s stock, valued at approximately $551,165.58. This trade represents a 42.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.99% of the company’s stock.

Institutional Investors Weigh In On H. B. Fuller

A number of hedge funds and other institutional investors have recently made changes to their positions in FUL. Cooke & Bieler LP grew its holdings in shares of H. B. Fuller by 94.9% during the 3rd quarter. Cooke & Bieler LP now owns 1,481,030 shares of the specialty chemicals company’s stock worth $87,795,000 after purchasing an additional 721,100 shares during the period. Norges Bank acquired a new position in H. B. Fuller during the second quarter valued at approximately $40,584,000. UBS Group AG lifted its position in H. B. Fuller by 200.8% during the third quarter. UBS Group AG now owns 820,871 shares of the specialty chemicals company’s stock valued at $48,661,000 after buying an additional 548,017 shares in the last quarter. Cramer Rosenthal Mcglynn LLC grew its stake in H. B. Fuller by 287.2% during the third quarter. Cramer Rosenthal Mcglynn LLC now owns 371,650 shares of the specialty chemicals company’s stock worth $22,031,000 after buying an additional 275,654 shares during the period. Finally, Kennedy Capital Management LLC increased its position in shares of H. B. Fuller by 131.2% in the third quarter. Kennedy Capital Management LLC now owns 439,444 shares of the specialty chemicals company’s stock worth $26,050,000 after acquiring an additional 249,350 shares in the last quarter. Hedge funds and other institutional investors own 95.93% of the company’s stock.

H. B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.